Tephrosia semiglabra
Tephrosia semiglabra · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Tephrosia semiglabra is a botanical species that has garnered scientific interest due to its unique chemical profile. Recent investigations into this plant have focused on its methanol (MeOH) extract to identify bioactive constituents. Through detailed analysis, researchers have isolated several specific compounds, including (-)-pseudosemiglabrin and (-)-semiglabrin. The presence of these specialized metabolites highlights the complex phytochemical makeup of the species. Understanding these chemical properties is essential for exploring the potential medicinal applications of Tephrosia semiglabra.
- Synonyms
- Cracca Semiglabra
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Synonyms
Tephrosia semiglabra is a botanical species that is frequently identified by its alternative nomenclature. In various scientific texts and herbarium records, you will find it listed under the synonym Cracca semiglabra. This taxonomic overlap often occurs as botanical classifications evolve over time to reflect more precise lineage studies. Understanding these naming variations is essential for researchers to ensure they are studying the correct plant. Recognizing both terms allows for seamless communication across different botanical databases and historical literature.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Tephrosia semiglabra is a distinct biological entity belonging to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further descends through the order Fabales, showcasing its specific evolutionary lineage. As a member of the family Fabaceae, it shares characteristics with many well-known legumes. Finally, this plant is defined by its placement within the genus Tephrosia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Tephrosia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Tephrosia semiglabra is a plant species widely distributed throughout the African continent, with a significant presence in Southern Africa. Its range encompasses several key regions, including the diverse landscapes of the Cape Provinces and the Free State. The species is also commonly found in the lush terrain of KwaZulu-Natal. Furthermore, its natural habitat extends into the highland areas of Lesotho. This broad distribution highlights the plant's ability to adapt to various ecological niches across the southern portion of the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Tephrosia semiglabra is a self-supporting herb characterized by its distinct growth form. This species exhibits significant variability in stature, ranging from a minimum height of only 0.1 meters. Under optimal conditions, the plant can reach a maximum height of up to 4 meters. Such flexibility in size allows it to adapt effectively to its surrounding environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Tephrosia semiglabra serves as a significant botanical source for several bioactive compounds. Through bioassay-directed fractionation of its methanol extract, researchers have successfully isolated two specific 7-oxygenated-8-prenylflavones. These identified constituents include both pseudosemiglabrin and semiglabrin. Notably, pseudosemiglabrin has demonstrated promising in vitro inhibitory effects on human platelet aggregation. This chemical profile highlights the medicinal potential inherent within the plant's complex secondary metabolites.
Conditions
Tephrosia semiglabra contains specific bioactive compounds that possess the ability to treat human platelet aggregation. Through bioassay-directed fractionation of a methanol extract, researchers isolated two distinct 7-oxygenated-8-prenylflavones. One of these identified constituents, (-)-pseudosemiglabrin, serves as a potent platelet aggregation inhibitor. In vitro testing specifically demonstrated that this compound effectively exerts inhibitory effects on human platelets. This chemical relationship highlights the plant's medicinal potential in managing blood clotting processes.
Preparations
Tephrosia semiglabra is prepared as a MeOH extract to facilitate the isolation of bioactive compounds. Through bioassay-directed fractionation of this methanol extract, researchers successfully identified specific 7-oxygenated-8-prenylflavones. These resulting compounds include (-)-pseudosemiglabrin and (-)-semiglabrin. The preparation of the MeOH extract was essential for uncovering the medicinal properties of the plant. Ultimately, this extraction process allowed for the discovery of (-)-pseudosemiglabrin's ability to inhibit human platelet aggregation.